Partnership, how it works

EU Prime Pharma offers to establish sales for Central Asia
starting from Uzbekistan with our own investments,
while you support us with manufacturing

We partner with manufacturers and local stakeholders to deliver quality-first commercialization and market access in Central Asian emerging markets, with a focus on cardio, women’s health, and ENT lines.

EU Prime:
– Imports EU quality established INNs (generics) in Uzbekistan
– Provides market access & commercialization
– Brings new solutions to the Uzbekistan pharma market to help patients and doctors for better care





If you’re exploring distribution, registration planning, or portfolio growth in this region, let’s connect.

We are reliable, ethical company that has already achieved results

Takeda

Goal: Strengthen commercial performance and build a scalable affiliate model.

Execution: Repositioned portfolio and redesigned commercial strategy.
Built and deployed a 25-rep internationally trained field force.
Institutionalized distributor and government stakeholder management

Impact: Scaled sales from USD 3m to USD 15m and established a scalable multinational operating model for sustained growth.

Grindeks

Goal: Restructure the commercial model and accelerate sustainable growth.

Execution: Rebuilt the distributor model into a structured commercial governance framework.
Built and led a 20-rep sales organization.
Integrated regulatory and legal infrastructure aligned with EU pharma standards.

Impact: Scaled sales to USD 7m and transitioned operations from distributor-driven execution to a controlled, scalable commercial platform.

Adamed

Goal: Establish and institutionalize a full affiliate structure in Uzbekistan.

Execution: Opened and structured the Uzbekistan affiliate from scratch.
Built a 15+ FTE commercial organization.
Implemented EU-style governance across sales, medical, and legal functions

Impact: Scaled sales to USD 5m and established a fully compliant, multinational-standard affiliate platform from day one.

Contact our Business Development Team via BD@euprimepharma.net

Pavel Papshev

11 years in management consulting  ​(IQVIA, KPMG, PwC) with a focus on Life Sciences Projects across the whole value chain in Central Asia, CIS, EU, and Global projects for J&J, MSD, Merck, Chiesi,  Novo Nordisk, Pfizer, TEVA, JGL Pharma, Belupo, Alkaloid, Darnitsa, PROMOMED, Lonza, etc.

Dr. Dinara Ibadullaeva​​

Marketing Director, Head of Representative Offices ​
in Uzbekistan ​
Over 22 years of experience in pharmaceutical companies such as Takeda, Grindeks, and Adamed Pharma​​

Agil Shikhiyev​​

8 years in management ​
consulting (IQVIA, KPMG) with focus on Life Sciences​
Did projects on portfolio & commercial strategies, go-to-market models, also HR projects in Central Asia, CIS, EU  for Alkaloid, Polpharma, Moderna, Dr. Reddy’s, PROMOMED, Valenta, Darnitsa, Viola, etc

Dr. Andrey Molchanov​

15+ years in pharma M&A, ​
business development and launch excellence   ​
In and out-license and global regulatory strategy for 60+ countries  ​
Executive, Managing Director background  for AMW GmbH, Fontane Pharma, Xendo group with Tier-1 Pharma day-to-day strategic business​

Viktor Abramov​


12 years in leading ​
pharma companies ( Ipsen, Novo Nordisk)​
Business development & portfolio expansion, sales excellence projects  in South Korea, Central Asia, CIS and EU  for IPSEN, Novo Nordisk, Samsung Biologics​



Shahriyor ​Uldashev​​​


Entrepreneur​
Technological and health products import ​
to Uzbekistan​,
Expert in logistics






Scroll to Top